Wong, Carlos K. H. http://orcid.org/0000-0002-6895-6071
Lau, Kristy T. K.
Au, Ivan C. H.
Chan, Sophelia H. S. http://orcid.org/0000-0002-2990-0163
Lau, Eric H. Y. http://orcid.org/0000-0002-6688-9637
Cowling, Benjamin J. http://orcid.org/0000-0002-6297-7154
Leung, Gabriel M. http://orcid.org/0000-0002-2503-6283
Funding for this research was provided by:
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (COVID190210)
Innovation and Technology Commission (AIR@InnoHK)
Article History
Received: 2 February 2024
Accepted: 29 May 2024
First Online: 8 June 2024
Competing interests
: C.K.H.W. reports the receipt of General Research Fund, Research Grant Council, Government of Hong Kong SAR; EuroQol Research Foundation; AstraZeneca and Boehringer Ingelheim, all outside the submitted work. B.J.C. reports honoraria from AstraZeneca, Fosun Pharma, GlaxoSmithKline, Haleon, Moderna, Pfizer, Roche, and Sanofi Pasteur. B.J.C. has provided scientific advice to Pfizer and AstraZeneca on issues related to COVID-19 disease burden and vaccine effectiveness. He has not provided scientific advice to either company related to COVID-19 antiviral effectiveness, and he has not received any funding from Pfizer or AstraZeneca for any research on antiviral effectiveness including the current work. All other authors declare no competing interests.